Patriot Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-77,013
Closed -$6.57M 84
2018
Q2
$6.57M Buy
77,013
+1,745
+2% +$143K 0.9% 44
2018
Q1
$5.82M Buy
75,268
+1,691
+2% +$136K 0.83% 45
2017
Q4
$6.21M Buy
73,577
+1,381
+2% +$118K 0.88% 44
2017
Q3
$6.18M Buy
72,196
+470
+0.7% +$38.5K 1% 38
2017
Q2
$5.9M Buy
71,726
+2,130
+3% +$174K 0.99% 41
2017
Q1
$5.85M Buy
69,596
+2,185
+3% +$175K 0.94% 41
2016
Q4
$4.96M Buy
67,411
+193
+0.3% +$14.4K 0.94% 47
2016
Q3
$5.39M Sell
67,218
-1,710
-2% -$137K 1.04% 38
2016
Q2
$5.43M Buy
+68,928
New +$5.19M 1.07% 36

Other funds holding LLY

Patriot Wealth Management's LLY Position: Q3 2018 in Review

Patriot Wealth Management sold out of Eli Lilly (LLY) in Q3 2018, closing a stake of 77,013 shares — an estimated $6.57M sold.

Patriot Wealth Management first reported a position in LLY in Q2 2016 and held it in 9 quarters. The position peaked at $6.57M in Q2 2018. 1,431 funds tracked by Wall St. Rank hold LLY as of Q3 2018.

  • Patriot Wealth Management reported no remaining Eli Lilly position as of Q3 2018 after selling out during the quarter.
  • Patriot Wealth Management sold 77,013 Eli Lilly shares in Q3 2018, an estimated $6.57M.
  • Patriot Wealth Management first reported a position in Eli Lilly in Q2 2016 and held it in 9 quarters.
  • Patriot Wealth Management's Eli Lilly position peaked at $6.57M in Q2 2018.
  • 1,431 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2018.

Based on Patriot Wealth Management's 13F filing for Q3 2018, filed 15 Oct 2018.